Skip to main content
Clinical Trials/CTRI/2021/09/036667
CTRI/2021/09/036667
Completed
Phase 2

A pilot randomized controlled trial to assess the impact of mindfulness meditation on health-related quality of life in hematopoietic cell transplant recipients

Postgraduate Institute of Medical Education Research PGIMER0 sites72 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanismHealth Condition 2: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue
Sponsor
Postgraduate Institute of Medical Education Research PGIMER
Enrollment
72
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Postgraduate Institute of Medical Education Research PGIMER

Eligibility Criteria

Inclusion Criteria

  • (1\) all adults (Age \= 18 years at the time of transplant),
  • (2\) all transplant recipients (autologous/ allogeneic)
  • (3\) those willing to adhere to the app\-based meditation practice for the period of the study

Exclusion Criteria

  • (1\)Those not willing to consent
  • (2\)Those without access to a smartphone

Outcomes

Primary Outcomes

Not specified

Similar Trials